These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 37546549)
1. Comprehensive bioinformatic analysis of mind bomb 1 gene in stomach adenocarcinoma. Wang D; Wang QH; Luo T; Jia W; Wang J World J Gastrointest Oncol; 2023 Jul; 15(7):1295-1310. PubMed ID: 37546549 [TBL] [Abstract][Full Text] [Related]
2. UBR1 is a prognostic biomarker and therapeutic target associated with immune cell infiltration in gastric cancer. Yuan W; Han J; Chen C; Qiu Y; Xu Y; Huang Y; Chen Z; Xu A; Sun M Aging (Albany NY); 2024 Aug; 16(16):12029-12049. PubMed ID: 39181686 [TBL] [Abstract][Full Text] [Related]
3. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets. Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873 [TBL] [Abstract][Full Text] [Related]
4. Construction of store-operated calcium entry-related gene signature for predicting prognosis and indicates immune microenvironment infiltration in stomach adenocarcinomas. Zhang Z; Wang C; Shi W; Wang Z; Fu W Sci Rep; 2024 Sep; 14(1):22342. PubMed ID: 39333689 [TBL] [Abstract][Full Text] [Related]
5. Upregulation of LIMK1 Is Correlated With Poor Prognosis and Immune Infiltrates in Lung Adenocarcinoma. Lu G; Zhou Y; Zhang C; Zhang Y Front Genet; 2021; 12():671585. PubMed ID: 34149814 [TBL] [Abstract][Full Text] [Related]
6. Expression and role of nuclear receptor-interacting protein 1 (NRIP1) in stomach adenocarcinoma. Fang D; Lu G Ann Transl Med; 2020 Oct; 8(20):1293. PubMed ID: 33209873 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of COMMD10 as a novel prognostic biomarker for gastric cancer. Zhao W; Lin J; Cheng S; Li H; Shu Y; Xu C PeerJ; 2023; 11():e14645. PubMed ID: 36919165 [TBL] [Abstract][Full Text] [Related]
8. High Endothelin Receptor Type A Expression as an Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Stomach Adenocarcinoma. Yan Y; Nie K; Zheng J; Jiang X; Huang Y; Zheng Z; Wen Y; Li P Cancer Manag Res; 2021; 13():5013-5026. PubMed ID: 34234547 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of the expression, prognostic, and immune infiltration for COL4s in stomach adenocarcinoma. Xu Y; Jin H; Chen Y; Yang Z; Xu D; Zhang X; Yang J; Wang Y BMC Med Genomics; 2024 Jun; 17(1):168. PubMed ID: 38907304 [TBL] [Abstract][Full Text] [Related]
10. Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma. Zhai Y; Liu X; Huang Z; Zhang J; Stalin A; Tan Y; Zhang F; Chen M; Shi R; Huang J; Wu C; Wu Z; Lu S; You L; Wu J Sci Rep; 2023 Jan; 13(1):1373. PubMed ID: 36697459 [TBL] [Abstract][Full Text] [Related]
11. Unveiling the role of RARs in stomach adenocarcinoma: clinical implications and prognostic biomarkers. Ren H; Huang L; Zhang H; Huang M; Meng J; Luo D Transl Cancer Res; 2024 Aug; 13(8):3974-3995. PubMed ID: 39262490 [TBL] [Abstract][Full Text] [Related]
12. Amino acid metabolism-related genes as potential biomarkers and the role of MATN3 in stomach adenocarcinoma: A bioinformatics, mendelian randomization and experimental validation study. Zhu W; Fu M; Li Q; Chen X; Liu Y; Li X; Luo N; Tang W; Zhang Q; Yang F; Chen Z; Zhang Y; Peng B; Zhang Q; Zhang Y; Peng X; Hu G Int Immunopharmacol; 2024 Dec; 143(Pt 1):113253. PubMed ID: 39353384 [TBL] [Abstract][Full Text] [Related]
13. Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinoma. Guo L; Liu D Eur J Med Res; 2022 Aug; 27(1):164. PubMed ID: 36045400 [TBL] [Abstract][Full Text] [Related]
15. Stromal Interaction Molecule 1 (STIM1) is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Solid Tumors. Zhang Z; Wang Z; Liu Y; Zhao L; Fu W J Environ Pathol Toxicol Oncol; 2023; 42(2):11-30. PubMed ID: 36749087 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry and Bioinformatics Identify GPX8 as a Potential Prognostic Biomarker and Target in Human Gastric Cancer. Zhang X; Xu H; Zhang Y; Sun C; Li Z; Hu C; Zhao D; Guo C Front Oncol; 2022; 12():878546. PubMed ID: 35712475 [TBL] [Abstract][Full Text] [Related]
17. PLVAP protein expression correlated with microbial composition, clinicopathological features, and prognosis of patients with stomach adenocarcinoma. Wen Y; Wang Y; Huang Y; Liu Z; Hui C J Cancer Res Clin Oncol; 2023 Aug; 149(10):7139-7153. PubMed ID: 36884119 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value and therapeutic potential of NEK family in stomach adenocarcinoma. Zhou X; Nie H; Wang C; Yu X; Yang X; He X; Ou C J Cancer; 2024; 15(10):3154-3172. PubMed ID: 38706902 [TBL] [Abstract][Full Text] [Related]
19. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis. Cui Y; Zhou Z; Chai Y; Zhang Y J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313 [TBL] [Abstract][Full Text] [Related]
20. LncRNA DIRC1 is a novel prognostic biomarker and correlated with immune infiltrates in stomach adenocarcinoma. Lin Y; Zhang Z; Li Y; Chen Y; Su M; Zhao W Medicine (Baltimore); 2022 Nov; 101(46):e31839. PubMed ID: 36401393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]